A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Recruiting

Phase 1

PF-08046876A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Sponsor:

Pfizer

Code:

NCT07090499

Conditions

Advanced/Metastatic Solid Tumors

Bladder Cancer

Urothelial Carcinoma

Advanced Non-Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046876

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-10. This information was provided to ClinicalTrials.gov by Pfizer on 2025-10-09.